This summary was created by AI, based on 1 opinions in the last 12 months.
Cellebrite DI Ltd. (CLBT) is highly praised for its ability to trace data efficiently for law enforcement and military agencies. It effectively utilizes AI to sift through vast amounts of information, allowing for quick and accurate identification of patterns and clues. With a substantial cash reserve and a strong customer base, the company shows promising growth potential. However, it is noted that CLBT is relatively smaller in market cap compared to other companies in the same field.
Cellebrite is a American stock, trading under the symbol CLBT-Q on the NASDAQ (CLBT). It is usually referred to as NASDAQ:CLBT or CLBT-Q
In the last year, there was no coverage of Cellebrite published on Stockchase.
Cellebrite was recommended as a Top Pick by on . Read the latest stock experts ratings for Cellebrite.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Cellebrite published on Stockchase.
On 2024-11-20, Cellebrite (CLBT-Q) stock closed at a price of $19.
It is very good at tracing data for the police, military and other agencies. One of the best use cases for AI is looking at data. This is so good for the overwhelming amount of info that police have to look at. CLBT scrubs the info to find clues and patterns and can find information quickly. It has $400 million in cash along with very good growth. With a market cap of less than $4 billion it is much smaller than other companies in the same field. The customer base gives confidence in the company. Buy 8 Hold 0 Sell 0
(Analysts’ price target is $22.43)